Patent Assignment
Reel/Frame 029198/0319
Change of Name
Recorded: 2012-10-25
Pages: 5
Assignor
AMYLIN PHARMACEUTICALS, INC.
Executed: 2012-08-08
Assignee
AMYLIN PHARMACEUTICALS, LLC
9360 TOWNE CENTRE DRIVE, ATTN: INTELLECTUAL PROPERTY GROUP, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(19)
Use of Exendins and Agonists Thereof for the Reduction of Food Intake
Formulations for Amylin Agonist Peptides
Polynucleotides Encoding Proexendin, and Methods and Uses Thereof
Patent:
6,723,530 →
Application:
09/019,172 →
Novel Anti-Diabetic Peptides
Patent:
6,087,334 →
Application:
09/138,056 →
Metabolic Intervention with Glp-1 to Improve the Function of Ischemic and Reperfused Tissue
Patent:
6,284,725 →
Application:
09/302,596 →
Use of Exendins and Agonists Thereof for the Treatment of Gestational Diabetes Mellitus
Patent:
6,506,724 →
Application:
09/323,867 →
Lipid Matrix-Assisted Chemical Ligation and Synthesis of Membrane Polypeptides
Patent:
6,451,543 →
Application:
09/384,302 →
Novel Exendin Agonist Compounds
Patent:
7,220,721 →
Application:
09/554,531 →
Novel Exendin Agonist Compounds
Patent:
7,223,725 →
Application:
09/554,533 →
Modified Exendins and Exendin Agonists
Patent:
6,924,264 →
Application:
09/561,226 →
Methods for Regulating Gastrointestinal Motility
Patent:
6,608,029 →
Application:
09/576,062 →
Novel Mixed Amylin Activity Compounds
Patent:
6,936,584 →
Application:
09/622,104 →
Inotropic and Diuretic Effects of Exendin and Glp-1
Patent:
6,703,359 →
Application:
09/622,105 →
Human Appetite Control by Glucagon-Like Peptide Receptor Binding Compounds
Patent:
6,998,387 →
Application:
09/646,433 →
Exendin Improves Beta-Cell Response in Subjects with Impaired Glucose Tolerance
Patent:
7,265,087 →
Application:
09/719,410 →
Uncoupling Protein 4 (Ucp-4)
Patent:
6,602,694 →
Application:
09/743,847 →
Treatment of Acute Coronary Syndrome with Glp-1
Novel Exendin Agonist Formulations and Methods of Administration Thereof
Patent:
6,902,744 →
Application:
09/889,330 →
Methods for Glucagon Suppression
Patent:
6,872,700 →
Application:
09/889,331 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Oct 1, 2012
From: ELI LILLY AND COMPANY
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 029057/0342 →
Release of Security Interest
Oct 1, 2012
From: ELI LILLY AND COMPANY
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 029057/0626 →
Amylin Pharmaceuticals, Llc Assigns an Equal and Undivided One-Half of Its Entire Right, Title and Interest to Astrazeneca Pharmaceuticals Lp
Oct 26, 2012
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 029195/0555 →